Loading...
OTCM
FZMD
Market cap5mUSD
Jul 11, Last price  
0.07USD
1D
0.00%
1Q
12.90%
Jan 2017
-56.25%
Name

Fuse Medical Inc

Chart & Performance

D1W1MN
P/E
3.54
P/S
0.32
EPS
0.02
Div Yield, %
Shrs. gr., 5y
1.04%
Rev. gr., 5y
-9.36%
Revenues
16m
-13.57%
0000000000941,0861,676,609567,60726,407,20626,342,03822,900,27721,398,93620,414,26818,644,78416,115,483
Net income
1m
-52.88%
-366,128-104,114-88,055-40,844-81,780-110,364-157,462-122,262-101,583-109,855-1,405,045-801,547-585,935699,6783,957,554-3,316,495-1,432,495-1,587,8913,098,1131,459,964
CFO
444k
+1,175.28%
-308,284-119,355-56,916-14,087-67,287-100,362-105,067-134,279-53,067-50,883-1,168,784-375,140-237,9061,604,5362,479,900-4,739236,654-1,778,32834,799443,786
Dividend
Oct 22, 20100.5 USD/sh

Profile

Fuse Medical, Inc. manufactures and distributes medical device implants in the United States. The company offers orthopedic implants, including internal and external fixation products for foot and ankle; upper and lower extremity plating and total joint reconstruction implants; soft tissue fixation and augmentation for sports medicine procedures; and full spinal implants for trauma, degenerative disc disease, and deformity indications. It also provides osteo-biologics and regenerative products, which include human allografts, tendons, synthetic skin and bone substitute materials, and regenerative tissues. The company serves hospitals, medical facilities, and sub-distributors. Fuse Medical, Inc. is based in Richardson, Texas.
IPO date
Oct 30, 1980
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
16,115
-13.57%
18,645
-8.67%
Cost of revenue
5,382
19,322
Unusual Expense (Income)
NOPBT
10,734
(678)
NOPBT Margin
66.61%
Operating Taxes
23
24
Tax Rate
0.22%
NOPAT
10,711
(701)
Net income
1,460
-52.88%
3,098
-295.11%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
1,794
2,147
Long-term debt
200
200
Deferred revenue
(2,650)
Other long-term liabilities
4,193
7,486
Net debt
(856)
(633)
Cash flow
Cash from operating activities
444
35
CAPEX
(444)
Cash from investing activities
Cash from financing activities
(353)
(440)
FCF
10,662
840
Balance
Cash
238
148
Long term investments
2,612
2,833
Excess cash
2,044
2,048
Stockholders' equity
(319)
(1,779)
Invested Capital
7,655
8,651
ROIC
131.37%
ROCE
146.32%
EV
Common stock shares outstanding
77,860
77,860
Price
Market cap
EV
EBITDA
10,865
(540)
EV/EBITDA
Interest
221
171
Interest/NOPBT
2.06%